ABSTRACT
In the context of high malaria burden and insufficient resources, several national malaria programs (NMPs) used subnational tailoring (SNT) as a tool for evidence-informed decision-making on their national malaria strategic plans and funding requests. The SNT process included the formation of an SNT team, determination of criteria for targeting interventions, data assembly and review, stratification, application of targeting criteria to determine preliminary plans, mathematical modeling, finalization of intervention plans, and monitoring and evaluation of the eventual implemented plan, all under the leadership of the NMP. Analysis steps of SNT were supported by the World Health Organization (WHO) and other partners. As SNT was a new approach, this study used semi-structured interviews to understand the perspectives and experiences of personnel from five NMPs (Burkina Faso, Ghana, Guinea, Nigeria, and Togo) that undertook SNT between 2019 and 2023. Participants reported that SNT outputs were used to inform national strategic plans and prioritized plans, that the process incentivized improvements in data collection and data quality, and that NMPs were strongly motivated to grow their capacity to conduct more steps of the SNT analysis process internally. Major challenges included the lack of resources available to implement the full strategic plans as well as challenges with data quality and alignment of stakeholders. Participants reported a moderate to strong sense of ownership over the process and were eager to extend, adapt, and reuse the SNT process in the future. Among countries supported by WHO, SNT was well-accepted and allowed NMPs to successfully use evidence to inform their decision-making, advocate for themselves, and mobilize resources.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
LO, GAO, and JG were funded by grants from the Bill & Melinda Gates Foundation: INV-002092 and INV-048410. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was reviewed and approved by Northwestern University’s Institutional Review Board (project STU00215997). The World Health Organization Research Ethics Review Committee granted this study an ERC exemption (project HBHI-SOC). Participants provided written and oral informed consent to participate.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Given the small sample, and identifiability of participants, the full transcripts cannot be provided. Codebooks and aggregated, anonymized analyses will be available upon request.
